Index -
P/E 88.95
EPS (ttm) 2.32
Insider Own 3.90%
Shs Outstand 38.68M
Perf Week -1.21%
Market Cap 7.98B
Forward P/E 53.71
EPS next Y 3.84
Insider Trans -0.74%
Shs Float 37.20M
Perf Month -6.33%
Income 90.95M
PEG -
EPS next Q 0.38
Inst Own 89.20%
Short Float 5.18%
Perf Quarter -16.43%
Sales 1.06B
P/S 7.54
EPS this Y 34.83%
Inst Trans 1.14%
Short Ratio 5.68
Perf Half Y -0.44%
Book/sh 30.48
P/B 6.76
EPS next Y 36.22%
ROA 6.21%
Short Interest 1.93M
Perf Year -28.50%
Cash/sh 7.47
P/C 27.59
EPS next 5Y -
ROE 8.35%
52W Range 180.93 - 348.67
Perf YTD -18.04%
Dividend Est. -
P/FCF 97.15
EPS past 5Y 66.20%
ROI 6.50%
52W High -40.88%
Beta 0.55
Dividend TTM -
Quick Ratio 3.49
Sales past 5Y 19.41%
Gross Margin 63.55%
52W Low 13.94%
ATR (14) 6.64
Dividend Ex-Date -
Current Ratio 6.06
EPS Y/Y TTM 4515.14%
Oper. Margin 8.67%
RSI (14) 37.11
Volatility 2.67% 2.81%
Employees 4200
Debt/Eq 0.20
Sales Y/Y TTM 24.95%
Profit Margin 8.59%
Recom 1.56
Target Price 278.08
Option/Short Yes / Yes
LT Debt/Eq 0.19
EPS Q/Q 1284.05%
Payout 0.00%
Rel Volume 0.99
Prev Close 205.70
Sales Surprise -0.68%
EPS Surprise 8.76%
Sales Q/Q 28.69%
Earnings May 07 AMC
Avg Volume 339.69K
Price 206.15
SMA20 -4.11%
SMA50 -11.46%
SMA200 -15.50%
Trades
Volume 336,365
Change 0.22%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-24 Downgrade
JP Morgan
Overweight → Neutral
$284 → $250
Sep-06-23 Initiated
Morgan Stanley
Equal-Weight
$265
Jul-19-23 Initiated
Robert W. Baird
Outperform
$375
Mar-29-23 Downgrade
Needham
Buy → Hold
Jan-30-23 Initiated
Piper Sandler
Overweight
$275
Nov-04-22 Upgrade
Citigroup
Neutral → Buy
$217 → $212
Oct-12-22 Initiated
Jefferies
Buy
$230
Oct-05-22 Downgrade
Citigroup
Buy → Neutral
$170 → $217
Sep-09-22 Upgrade
Needham
Hold → Buy
Jul-18-22 Initiated
RBC Capital Mkts
Outperform
$195
Apr-19-22 Initiated
Deutsche Bank
Buy
$250
Mar-08-22 Initiated
Needham
Hold
Sep-16-21 Initiated
Truist
Buy
$350
Jun-04-21 Upgrade
BTIG Research
Neutral → Buy
$291
Dec-16-20 Downgrade
BTIG Research
Buy → Neutral
Oct-07-20 Resumed
Canaccord Genuity
Buy
$253
Sep-29-20 Initiated
BTIG Research
Buy
$233
Sep-08-20 Downgrade
BofA Securities
Buy → Neutral
Mar-05-20 Initiated
Citigroup
Buy
$200
Jun-13-19 Reiterated
BofA/Merrill
Buy
$150 → $180
Show Previous Ratings
Apr-24-24 11:43AM
Apr-23-24 09:45AM
09:00AM
Apr-09-24 04:05PM
Apr-08-24 09:35AM
01:55AM
Loading…
Apr-04-24 01:55AM
Mar-05-24 09:49AM
Feb-27-24 09:45AM
Feb-26-24 11:42AM
Feb-23-24 11:40AM
(Thomson Reuters StreetEvents) -9.25%
10:44AM
12:11AM
Feb-22-24 05:40PM
04:35PM
04:35PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Feb-20-24 07:12AM
Feb-18-24 01:26PM
Feb-15-24 10:00AM
Feb-01-24 04:05PM
Jan-18-24 11:39AM
Dec-22-23 09:37AM
Dec-21-23 07:01AM
Dec-19-23 10:30AM
Dec-18-23 07:50PM
Nov-30-23 09:55AM
07:37AM
Nov-28-23 09:54AM
09:00AM
Nov-17-23 01:03PM
04:05PM
Loading…
Nov-14-23 04:05PM
10:19AM
Nov-10-23 05:43PM
Nov-03-23 08:59AM
08:29AM
08:18AM
Nov-02-23 06:09PM
05:20PM
(Associated Press Finance)
04:05PM
Nov-01-23 04:05PM
Oct-27-23 04:44AM
Oct-24-23 11:42AM
Oct-12-23 11:03AM
Oct-11-23 11:38AM
Oct-05-23 04:05PM
Oct-04-23 11:02PM
09:50AM
Sep-27-23 09:55AM
Sep-22-23 08:09AM
05:20AM
Sep-21-23 09:40AM
Sep-20-23 01:45PM
Sep-19-23 06:20AM
Sep-14-23 07:38PM
01:09PM
Sep-11-23 07:55AM
Sep-06-23 11:42AM
09:36AM
Sep-05-23 09:40AM
Sep-01-23 09:55AM
Aug-31-23 11:31AM
Aug-30-23 08:15AM
Aug-23-23 04:05PM
05:58AM
Aug-22-23 10:28AM
Aug-18-23 12:41PM
12:35PM
Aug-17-23 11:21AM
11:12AM
09:09AM
09:00AM
Aug-16-23 10:21AM
Aug-14-23 01:22PM
11:31AM
Aug-11-23 10:34AM
Aug-10-23 11:48AM
11:37AM
Aug-09-23 10:31AM
Aug-08-23 12:48PM
11:21AM
Aug-07-23 12:12PM
Aug-04-23 12:30PM
12:08PM
10:07AM
07:22AM
Aug-02-23 02:20PM
11:51AM
07:26AM
(Thomson Reuters StreetEvents)
Aug-01-23 05:25PM
04:19PM
04:05PM
Jul-26-23 04:05PM
Jul-25-23 04:46AM
Jul-12-23 07:43AM
Jul-11-23 06:05PM
Jul-08-23 10:21AM
Jul-05-23 04:05PM
Jun-27-23 04:41AM
Jun-26-23 08:00AM
Jun-21-23 08:00PM
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Roberts Johanna EVP, Gen. Counsel & Secretary Apr 01 '24 Sale 217.07 600 130,242 64,281 Apr 03 07:42 PM Kassing Don W. Director Apr 01 '24 Sale 223.18 170 37,941 1,175 Apr 03 07:42 PM Elsesser Adam CEO and President Mar 06 '24 Option Exercise 7.75 5,000 38,750 5,000 Mar 08 08:10 PM Bose Arani Director Mar 04 '24 Sale 250.20 7,500 1,876,500 164,294 Mar 05 07:44 PM Kassing Don W. Director Mar 01 '24 Sale 234.72 778 182,612 1,345 Mar 05 07:46 PM Roberts Johanna EVP, Gen. Counsel & Secretary Mar 01 '24 Sale 237.68 600 142,607 62,997 Mar 05 07:45 PM Grewal Harpreet Director Jan 03 '24 Sale 240.82 170 40,939 8,980 Jan 04 07:34 PM Sarna Surbhi Director Jan 02 '24 Sale 247.68 85 21,053 2,295 Jan 04 07:36 PM Roberts Johanna EVP, Gen. Counsel & Secretary Dec 27 '23 Option Exercise 22.04 2,450 53,998 63,597 Dec 29 07:31 PM Roberts Johanna EVP, Gen. Counsel & Secretary Dec 01 '23 Sale 226.42 600 135,851 62,251 Dec 05 07:55 PM O'Rourke Bridget Director Nov 30 '23 Sale 226.41 150 33,962 4,214 Dec 04 07:41 PM Roberts Johanna EVP, Gen. Counsel & Secretary Nov 14 '23 Sale 214.14 600 128,482 63,037 Nov 16 07:35 PM Elsesser Adam CEO and President Oct 11 '23 Option Exercise 7.75 9,670 74,942 9,670 Oct 13 07:33 PM Elsesser Adam CEO and President Oct 11 '23 Sale 215.76 9,670 2,086,417 0 Oct 13 07:33 PM Shiu Lambert Chief Accounting Officer Oct 09 '23 Option Exercise 12.36 2,750 33,990 19,466 Oct 11 07:31 PM Roberts Johanna EVP, Gen. Counsel & Secretary Oct 02 '23 Sale 237.82 600 142,691 63,637 Oct 04 07:30 PM Grewal Harpreet Director Oct 02 '23 Sale 240.99 170 40,968 9,150 Oct 04 07:44 PM Sarna Surbhi Director Oct 02 '23 Sale 240.99 85 20,484 2,380 Oct 04 07:34 PM Elsesser Adam CEO and President Sep 11 '23 Option Exercise 7.75 9,666 74,912 9,666 Sep 13 07:48 PM Elsesser Adam CEO and President Sep 11 '23 Sale 298.76 9,666 2,887,821 0 Sep 13 07:48 PM Kassing Don W. Director Sep 08 '23 Sale 288.66 444 128,165 1,458 Sep 12 08:03 PM Roberts Johanna EVP, Gen. Counsel & Secretary Sep 01 '23 Sale 265.11 600 159,067 64,237 Sep 06 08:03 PM Grewal Harpreet Director Sep 01 '23 Sale 266.62 340 90,651 9,320 Sep 06 08:02 PM O'Rourke Bridget Director Sep 01 '23 Sale 266.62 100 26,662 4,364 Sep 06 07:59 PM Sarna Surbhi Director Sep 01 '23 Sale 266.62 85 22,663 2,465 Sep 06 08:01 PM Roberts Johanna EVP, Gen. Counsel & Secretary Aug 14 '23 Sale 249.85 600 149,910 64,837 Aug 16 08:07 PM Elsesser Adam CEO and President Aug 11 '23 Option Exercise 7.75 9,666 74,912 9,666 Aug 14 08:57 PM Elsesser Adam CEO and President Aug 11 '23 Sale 247.21 9,666 2,389,573 0 Aug 14 08:57 PM Kassing Don W. Director Aug 08 '23 Sale 251.00 323 81,073 1,902 Aug 09 08:09 PM Wilder Thomas Director Aug 07 '23 Sale 253.48 340 86,183 340 Aug 09 08:11 PM Elsesser Adam CEO and President Jul 11 '23 Option Exercise 7.75 9,666 74,912 9,666 Jul 13 09:08 PM Elsesser Adam CEO and President Jul 11 '23 Sale 322.98 9,666 3,121,956 0 Jul 13 09:08 PM Roberts Johanna EVP, Gen. Counsel & Secretary Jul 03 '23 Sale 340.18 900 306,162 65,437 Jul 06 08:22 PM Sarna Surbhi Director Jul 03 '23 Sale 341.45 27 9,219 2,550 Jul 06 08:23 PM Elsesser Adam CEO and President Jun 12 '23 Option Exercise 7.75 9,666 74,912 9,666 Jun 14 08:43 PM Elsesser Adam CEO and President Jun 12 '23 Sale 324.49 9,666 3,136,481 0 Jun 14 08:43 PM Roberts Johanna EVP, Gen. Counsel & Secretary Jun 01 '23 Sale 309.30 900 278,368 66,337 Jun 05 07:28 PM Roberts Johanna EVP, Gen. Counsel & Secretary May 12 '23 Option Exercise 22.04 652 14,370 70,425 May 16 07:32 PM Roberts Johanna EVP, Gen. Counsel & Secretary May 12 '23 Sale 319.67 1,500 479,505 68,925 May 16 07:32 PM Elsesser Adam CEO and President May 11 '23 Option Exercise 7.75 9,666 74,912 9,666 May 15 07:31 PM Elsesser Adam CEO and President May 11 '23 Sale 318.52 9,666 3,078,862 0 May 15 07:31 PM Bose Arani Director May 01 '23 Sale 285.87 5,000 1,429,328 182,629 May 03 07:50 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite